A Phase I Study of RO7589831 in Participants with Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Advanced solid tumorsMedDRA version: 21.0Level: LLTClassification code: 10049280Term: Solid tumour Class: 10029104MedDRA version: 22.0Level: PTClassification code: 10078672Term: DNA mismatch repair protein gene mutation Class: 100000004850MedDRA version: 21.0Level: LLTClassification code: 10080676Term: Microsatellite instability Class: 10010331Therapeutic area: Diseases [C] - Neoplasms [C04]
- Registration Number
- CTIS2023-503170-20-01
- Lead Sponsor
- F. Hoffmann-La Roche AG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 49
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method